DK498286A - Fremgangsmaade og mellemprodukter til fremstilling af c(3)--c(4)-trans-konfigurerede gamma-butyrolactamer i form af deres isomere, isomerblandinger, racemater eller optiske antipoder - Google Patents

Fremgangsmaade og mellemprodukter til fremstilling af c(3)--c(4)-trans-konfigurerede gamma-butyrolactamer i form af deres isomere, isomerblandinger, racemater eller optiske antipoder Download PDF

Info

Publication number
DK498286A
DK498286A DK498286A DK498286A DK498286A DK 498286 A DK498286 A DK 498286A DK 498286 A DK498286 A DK 498286A DK 498286 A DK498286 A DK 498286A DK 498286 A DK498286 A DK 498286A
Authority
DK
Denmark
Prior art keywords
butyrolactames
racemates
intermediates
isomers
trans
Prior art date
Application number
DK498286A
Other languages
English (en)
Other versions
DK498286D0 (da
Inventor
Wolfgang Hartwig
Original Assignee
Bayer Ag
Chinese Acad Med Science
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ag, Chinese Acad Med Science filed Critical Bayer Ag
Publication of DK498286D0 publication Critical patent/DK498286D0/da
Publication of DK498286A publication Critical patent/DK498286A/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/18Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D207/22Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/24Oxygen or sulfur atoms
    • C07D207/262-Pyrrolidones
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/18Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D207/22Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/24Oxygen or sulfur atoms
    • C07D207/262-Pyrrolidones
    • C07D207/2732-Pyrrolidones with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to other ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/18Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D207/22Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/24Oxygen or sulfur atoms
    • C07D207/262-Pyrrolidones
    • C07D207/2732-Pyrrolidones with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to other ring carbon atoms
    • C07D207/277Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D207/282-Pyrrolidone-5- carboxylic acids; Functional derivatives thereof, e.g. esters, nitriles

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pyrrole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
DK498286A 1985-10-18 1986-10-17 Fremgangsmaade og mellemprodukter til fremstilling af c(3)--c(4)-trans-konfigurerede gamma-butyrolactamer i form af deres isomere, isomerblandinger, racemater eller optiske antipoder DK498286A (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE3537074 1985-10-18
DE19863632589 DE3632589A1 (de) 1985-10-18 1986-09-25 Verfahren zur herstellung von (gamma)-butyrolactamen

Publications (2)

Publication Number Publication Date
DK498286D0 DK498286D0 (da) 1986-10-17
DK498286A true DK498286A (da) 1987-04-19

Family

ID=25837071

Family Applications (1)

Application Number Title Priority Date Filing Date
DK498286A DK498286A (da) 1985-10-18 1986-10-17 Fremgangsmaade og mellemprodukter til fremstilling af c(3)--c(4)-trans-konfigurerede gamma-butyrolactamer i form af deres isomere, isomerblandinger, racemater eller optiske antipoder

Country Status (11)

Country Link
US (2) US4731455A (da)
EP (1) EP0222163B1 (da)
JP (2) JPH0794431B2 (da)
KR (1) KR870003980A (da)
CN (1) CN1019486B (da)
CA (1) CA1279650C (da)
DE (2) DE3632589A1 (da)
DK (1) DK498286A (da)
ES (1) ES2009757B3 (da)
HU (1) HU198450B (da)
IL (1) IL80305A (da)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3616989A1 (de) * 1986-05-21 1987-11-26 Bayer Ag Enantiomerenreine 4,5-disubstituierte (gamma)-butyrolactame, verfahren zu ihrer herstellung und ihre verwendung
DE3717395A1 (de) * 1987-05-23 1988-12-08 Basf Ag 5-phenyl-1,2,3a,4,5,9b-hexahydro-3h-benz(e) indole, ihre herstellung und verwendung als arzneimittel
DE3717394A1 (de) * 1987-05-23 1988-12-01 Basf Ag 3-phenyl-2-styryl-pyrrolidine, ihre herstellung und verwendung
EG18833A (en) * 1988-12-09 1994-11-30 Kumiai Chemical Industry Co Cyclic amide compounds and herbicides
DE3927370A1 (de) * 1989-08-19 1991-02-21 Bayer Ag Verfahren zur herstellung von clausenamid und neoclausenamid und deren derivate
AU2001296961A1 (en) * 2000-09-29 2002-04-08 Bayer Pharmaceuticals Corporation 17-beta-hydroxysteroid dehydrogenase-ii inhibitors
US6787564B2 (en) * 2002-03-26 2004-09-07 Institute Of Materia Medica, Chinese Academy Of Medical Sciences Optically active clausenamides, process of the preparation thereof, pharmaceutical composition containing the same and their medical use
JP6059510B2 (ja) * 2012-11-05 2017-01-11 花王株式会社 セラミド産生促進剤
CN118084757B (zh) * 2023-10-10 2025-09-16 广东药科大学 2个内酰胺类物质及其应用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT374457B (de) * 1977-08-18 1984-04-25 Hoechst Ag Verfahren zur herstellung von neuen benzolsulfonamidderivaten
CH646149A5 (de) * 1981-02-05 1984-11-15 Hoffmann La Roche Pyrrolidin-derivat.
US4454327A (en) * 1982-05-24 1984-06-12 Warner-Lambert Company 5-Oxo-2,2-pyrrolidinedipropanoic acid and ester derivatives thereof
DE3346623A1 (de) * 1983-12-14 1985-07-04 Bayer Ag, 5090 Leverkusen N-glycosylierte harnstoffe, carbamate und thiocarbamate, verfahren zu ihrer herstellung sowie ihre verwendung
DE3508025A1 (de) * 1985-03-07 1986-09-11 Bayer Ag, 5090 Leverkusen Substituierte o-sulfonyl-glycosylamide, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel
JPS61245606A (ja) * 1985-04-23 1986-10-31 Alps Electric Co Ltd マイクロ波発振器

Also Published As

Publication number Publication date
EP0222163B1 (de) 1989-07-19
JPH0853413A (ja) 1996-02-27
HU198450B (en) 1989-10-30
DK498286D0 (da) 1986-10-17
US4803285A (en) 1989-02-07
CA1279650C (en) 1991-01-29
HUT46661A (en) 1988-11-28
EP0222163A1 (de) 1987-05-20
CN86106592A (zh) 1987-06-03
JPH0794431B2 (ja) 1995-10-11
JPS62187451A (ja) 1987-08-15
DE3664464D1 (en) 1989-08-24
CN1019486B (zh) 1992-12-16
JP2520582B2 (ja) 1996-07-31
KR870003980A (ko) 1987-05-06
DE3632589A1 (de) 1987-04-23
US4731455A (en) 1988-03-15
IL80305A0 (en) 1987-01-30
ES2009757B3 (es) 1989-10-16
IL80305A (en) 1990-04-29

Similar Documents

Publication Publication Date Title
DK213184A (da) Fremgangsmaade til fremstilling af n-alkylerede dipeptider og deres estere, mellemprodukter dertil og disses fremstilling
DK117885A (da) Fremgangsmaade til krystallisation af sukker
DK437188A (da) Fremgangsmaade til kryopreservering af hjerteklapper
DK150204C (da) Analogifremgangsmaade til fremstilling af dipeptidyl-agmatiner eller deres hydrochlorider
DK443789A (da) Sonde til behandling af aareknuder
DK609885D0 (da) Fremgangsmaade til modifikation af organismer
DK6185D0 (da) Fremgangsmaade til decarboxylering af kolofonium-syrer
DK498286A (da) Fremgangsmaade og mellemprodukter til fremstilling af c(3)--c(4)-trans-konfigurerede gamma-butyrolactamer i form af deres isomere, isomerblandinger, racemater eller optiske antipoder
DK167986D0 (da) Mellemprodukter til fremstilling af epipodophyllotoxin og dermed beslaegtede forbindelser, deres fremstilling og anvendelse
DK506486D0 (da) Fremgangsmaade og samlestykke til samling af raer af kompositmateriale
DK111188D0 (da) Mellemprodukter til brug ved fremstillingen af vitamin-d-derivater
DK438686D0 (da) Baerematrix til optagelse af katalytisk virkende forbindelser og fremgangsmaade til fremstilling af baerematrixen
IT8167770A0 (it) Procedimento per la produzione dil prolina per fermentazione
DK487885D0 (da) Pyrazolin-forbindelser til anvendelse som insekticider og fremgangsmaade til fremstilling af saadanne forbindelser
DK296485A (da) Fremgangsmaade til fremstilling af l-phenylalanin
DE3581238D1 (de) Mikrobiologische herstellung von l-phenylalanin.
DK437287D0 (da) 2,3-dihydrofuranderivater, deres fremstilling og deres anvendelse som mellemprodukter til fremstilling af tetrahydrofuranderivater
NO844928L (no) Fremgangsmaate for aa separere nitreringsisomerer av substituerte benzenforbindelser
DK258988A (da) Individuelle isomere af endo-bicyclo(2.21)heptyladenosin
IS3488A7 (is) Búnaður til framleiðslu grinda
DK148486D0 (da) Pyridylphosphorsyreestere, deres fremstilling og anvendelse til bekaempelse af skadelige organismer
DK559786A (da) Mellemprodukter til fremstilling af beta-lactamantibiotika
FR2574838B1 (fr) Perfectionnements apportes aux poutres en i essentiellement constituees en bois
DK602288D0 (da) Mellemprodukter til fremstilling af halogenerede proteaseinhibitorer
DK52981A (da) Halogenalkylamider fremgangsmaader og mellemprodukter til deres fremstilling samt deres anvendelse som modgiftsmidler og i ukrudtbekaempelsesmidler

Legal Events

Date Code Title Description
ATS Application withdrawn